Amylyx Pharmaceuticals Inc
NASDAQ:AMLX

Watchlist Manager
Amylyx Pharmaceuticals Inc Logo
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Watchlist
Price: 4.05 USD 2.27% Market Closed
Market Cap: 277.6m USD
Have any thoughts about
Amylyx Pharmaceuticals Inc?
Write Note

Intrinsic Value

AMLX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one AMLX stock under the Base Case scenario is 1.42 USD. Compared to the current market price of 4.05 USD, Amylyx Pharmaceuticals Inc is Overvalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMLX Intrinsic Value
1.42 USD
Overvaluation 65%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Amylyx Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
AMLX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AMLX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about AMLX?
Bearish
Neutral
Bullish

Fundamental Analysis

4.05 USD
+2.27%
+2.27%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Amylyx Pharmaceuticals Inc
US
Pharmaceuticals
Market Cap
277.6m USD
IPO
Jan 7, 2022
Employees
205
United States of America
Market Cap
277.6m USD
Industry
Pharmaceuticals
IPO
Jan 7, 2022
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Amylyx Pharmaceuticals Inc

Provide an overview of the primary business activities
of Amylyx Pharmaceuticals Inc.

What unique competitive advantages
does Amylyx Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Amylyx Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Amylyx Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Amylyx Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amylyx Pharmaceuticals Inc.

Provide P/S
for Amylyx Pharmaceuticals Inc.

Provide P/E
for Amylyx Pharmaceuticals Inc.

Provide P/OCF
for Amylyx Pharmaceuticals Inc.

Provide P/FCFE
for Amylyx Pharmaceuticals Inc.

Provide P/B
for Amylyx Pharmaceuticals Inc.

Provide EV/S
for Amylyx Pharmaceuticals Inc.

Provide EV/GP
for Amylyx Pharmaceuticals Inc.

Provide EV/EBITDA
for Amylyx Pharmaceuticals Inc.

Provide EV/EBIT
for Amylyx Pharmaceuticals Inc.

Provide EV/OCF
for Amylyx Pharmaceuticals Inc.

Provide EV/FCFF
for Amylyx Pharmaceuticals Inc.

Provide EV/IC
for Amylyx Pharmaceuticals Inc.

Show me price targets
for Amylyx Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Amylyx Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Amylyx Pharmaceuticals Inc?

What are the Net Income projections
for Amylyx Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Amylyx Pharmaceuticals Inc?

What are the EPS projections
for Amylyx Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Amylyx Pharmaceuticals Inc?

What are the EBIT projections
for Amylyx Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Amylyx Pharmaceuticals Inc?

Compare the revenue forecasts
for Amylyx Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amylyx Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amylyx Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amylyx Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Amylyx Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Amylyx Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Amylyx Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Amylyx Pharmaceuticals Inc.

Provide ROE
for Amylyx Pharmaceuticals Inc.

Provide ROA
for Amylyx Pharmaceuticals Inc.

Provide ROIC
for Amylyx Pharmaceuticals Inc.

Provide ROCE
for Amylyx Pharmaceuticals Inc.

Provide Gross Margin
for Amylyx Pharmaceuticals Inc.

Provide Operating Margin
for Amylyx Pharmaceuticals Inc.

Provide Net Margin
for Amylyx Pharmaceuticals Inc.

Provide FCF Margin
for Amylyx Pharmaceuticals Inc.

Show all solvency ratios
for Amylyx Pharmaceuticals Inc.

Provide D/E Ratio
for Amylyx Pharmaceuticals Inc.

Provide D/A Ratio
for Amylyx Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Amylyx Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Amylyx Pharmaceuticals Inc.

Provide Quick Ratio
for Amylyx Pharmaceuticals Inc.

Provide Current Ratio
for Amylyx Pharmaceuticals Inc.

Provide Cash Ratio
for Amylyx Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Amylyx Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Amylyx Pharmaceuticals Inc?

What is the current Free Cash Flow
of Amylyx Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amylyx Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amylyx Pharmaceuticals Inc

Current Assets 245.3m
Cash & Short-Term Investments 234.4m
Receivables 1.7m
Other Current Assets 9.1m
Non-Current Assets 5.5m
PP&E 3.5m
Other Non-Current Assets 1.9m
Current Liabilities 53.9m
Accounts Payable 1.5m
Accrued Liabilities 52.4m
Non-Current Liabilities 595k
Other Non-Current Liabilities 595k
Efficiency

Earnings Waterfall
Amylyx Pharmaceuticals Inc

Revenue
196.5m USD
Cost of Revenue
-41.5m USD
Gross Profit
155m USD
Operating Expenses
-275.6m USD
Operating Income
-120.6m USD
Other Expenses
-138.9m USD
Net Income
-259.5m USD

Free Cash Flow Analysis
Amylyx Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AMLX Profitability Score
Profitability Due Diligence

Amylyx Pharmaceuticals Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Negative 1-Year Revenue Growth
22/100
Profitability
Score

Amylyx Pharmaceuticals Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

AMLX Solvency Score
Solvency Due Diligence

Amylyx Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Amylyx Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMLX Price Targets Summary
Amylyx Pharmaceuticals Inc

Wall Street analysts forecast AMLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMLX is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 12.6 USD.

Lowest
Price Target
3.03 USD
25% Downside
Average
Price Target
7.65 USD
89% Upside
Highest
Price Target
12.6 USD
211% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AMLX?

Click here to dive deeper.

Dividends

Amylyx Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AMLX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AMLX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

AMLX News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one AMLX stock?

The intrinsic value of one AMLX stock under the Base Case scenario is 1.42 USD.

Is AMLX stock undervalued or overvalued?

Compared to the current market price of 4.05 USD, Amylyx Pharmaceuticals Inc is Overvalued by 65%.

Back to Top